Progress in treatments for colorectal cancer peritoneal metastases during the years 2010-2015. A systematic review
详细信息 查看全文
- 作者：Dario BarattiaAuthor Vitae ; Shigeki KusamuraaAuthor Vitae ; Filippo PietrantoniobAuthor Vitae ; Marcello GuaglioaAuthor Vitae ; Monica NigerbAuthor Vitae ; Marcello Deracoa ; marcello.deraco@istitutotumori.mi.it" class="auth_mail" title="E-mail the corresponding authorAuthor Vitae
- 关键词：CCR ; completeness of cytoreduction ; CRC ; colorectal cancer ; CRS ; cytoreductive surgery ; EPIC ; early postoperative intraperitoneal chemotherapy ; EGFR ; epidermal growth factor receptor ; HIPEC ; hyperthermic intraperitoneal chemotherapy ; LM ; liver metastases ; PCI ; peritoneal cancer index ; PM ; peritoneal metastases ; PSDSS ; peritoneal surface disease severity score ; QOL ; quality of life ; RFA ; radio frequency ablation ; SPIC ; sequential postoperative intraperitoneal chemotherapy ; sCT ; systemic chemother
- 刊名：Critical Reviews in Oncology and Hematology
- 出版年：2016
- 出版时间：April 2016
- 年：2016
- 卷：100
- 期：Complete
- 页码：209-222
- 全文大小：1339 K
文摘
- class="listitem" id="list_lis0005">
- class="label">•
The treatment paradigm of colorectal cancer peritoneal metastases is rapidly evolving.
- class="label">•
We systematically reviewed the medical literature of the last five years.
- class="label">•
Survival improvements have been associated to cytoreductive surgery and HIPEC.
- class="label">•
Progress in epidemiology and systemic therapy of peritoneal metastases was addressed.
- class="label">•
Cytoreductive surgery with HIPEC is increasingly accepted as a treatment option.